Clinical Trials Browser

Approved for marketing × INDUSTRY × PM 01183 × Clear all

NCT04291937 2020-06-19

A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA

Approved for marketing

Small Cell Lung Carcinoma